Cystic fibrosis: the model rare disease for pharmacoeconomical analyses

Abstract

This study provides a brief overview of pharmacoeconomic studies in cystic fibrosis, the most common genetic disorder in European-derived populations, which serves as a model for other rare diseases.

Keywords

• cystic fibrosis
• genetic basis
• multidisciplinary treatment
• treatment costs
• pharmacoeconomics